Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20249
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBerghen, Charlien-
dc.contributor.authorAlbersen, Maarten-
dc.contributor.authorBlanchard, Pierre-
dc.contributor.authorBossi, Alberto-
dc.contributor.authorBriganti, Alberto-
dc.contributor.authorCozzarini, Cesare-
dc.contributor.authorDecaestecker, Karel-
dc.contributor.authorFonteyne, Valérie-
dc.contributor.authorHaustermans, Karin-
dc.contributor.authorJoniau, Steven-
dc.contributor.authorLim Joon, Daryl-
dc.contributor.authorKhoo, Vincent-
dc.contributor.authorNguyen, Paul L-
dc.contributor.authorOst, Piet-
dc.contributor.authorVilleirs, Geert-
dc.contributor.authorVulsteke, Christof-
dc.contributor.authorZietman, Anthony-
dc.contributor.authorDe Meerleer, Gert-
dc.date2019-01-25-
dc.date.accessioned2019-02-04T23:34:12Z-
dc.date.available2019-02-04T23:34:12Z-
dc.date.issued2019-
dc.identifier.citationBJU International 2019; 124(1): 35-39en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20249-
dc.description.abstractGerm cell tumors (GCT), accounting for 95% of malignant testicular tumors, can be divided into two groups: seminoma (SGCT) and non-seminoma (NSGCT). Seminomas typically arise in men in the fourth decade of life, compromising 60% of the GCT. At diagnosis, approximately 75% present with local disease (Stage I); 15% is detected with metastatic regional lymph nodes (Stage II) and 5-10% present with juxtaregional or visceral metastasis (Stage III) . This article is protected by copyright. All rights reserved.en_US
dc.language.isoeng-
dc.titleReadressing the rationale of irradiation in Stage I seminoma guidelines: A critical essay.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleBJU Internationalen_US
dc.identifier.affiliationDepartment of Radiation Oncology, Leuven University Hospital, Leuven, Belgiumen_US
dc.identifier.affiliationOlivia Newton-John Cancer Wellness and Research Centreen_US
dc.identifier.affiliationDepartment of Urology, Leuven University Hospital, Leuven, Belgiumen_US
dc.identifier.affiliationDepartment of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, Franceen_US
dc.identifier.affiliationDepartment of Urology, San Raffaele Hospital, Milan, Italyen_US
dc.identifier.affiliationDepartment of Radiation Oncology, San Raffaele Hospital, Milan, Italyen_US
dc.identifier.affiliationDepartment of Urology, Ghent University Hospital, Ghent, Belgiumen_US
dc.identifier.affiliationDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgiumen_US
dc.identifier.affiliationRoyal Marsden NHS Foundation Trust, London, United Kingdomen_US
dc.identifier.affiliationDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Bringham Women's Hospital, Boston, Massachusetts, United States of Americaen_US
dc.identifier.affiliationDepartment of Radiology, Ghent University Hospital, Ghent, Belgiumen_US
dc.identifier.affiliationDepartment of Oncology, Ghent Maria Middelares Hospital, Ghent, Belgium Department of Molecular Imaging, Pathology, Radiotherapy& Oncology (MIPRO) Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgiumen_US
dc.identifier.affiliationDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of Americaen_US
dc.identifier.doi10.1111/bju.14686en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-4785-3409en_US
dc.identifier.orcid0000-0002-2203-4848en_US
dc.identifier.orcid0000-0002-1947-9694en_US
dc.identifier.orcid0000-0001-9661-1436en_US
dc.identifier.pubmedid30680874-
dc.type.austinJournal Article-
dc.type.austinReview-
local.name.researcherLim Joon, Daryl
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptRadiation Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.